Thanks Barman. I think Lonza's Singaporean Facility has been approved for other product lines by the FDA (rather than Rem-L). I agree BLA would cover considerations around manufacturing, thanks for noting that. Hence FDA should have all the information to make a decision (or inquire further) re Rem-L production at the Singaporean facility. From strength to strength.
Thanks Barman. I think Lonza's Singaporean Facility has...
-
- There are more pages in this discussion • 14,234 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 45345 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 3875 | 2 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |